DRIO · DarioHealth Corp
United States · RS rating 4 · As of 2026-11-03
| Price | 3.00 USD |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 4 / 6 / 9 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 27 / 6 / 51 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +168.0% |
| Sales growth Q/Q | +4.5% |
| Distance from 52-week high | +78.6% |
| Market cap (USD) | $52.6M |